HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

glembatumumab vedotin

a conjugate of an anti-glycoprotein non-metastatic melanoma protein B mAb and monomethyl auristatin E for the treatment of melanoma and breast cancer
Also Known As:
CDX-011; CR-011-VCMMAE
Networked: 25 relevant articles (3 outcomes, 12 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hawthorne, Thomas: 8 articles (05/2021 - 10/2014)
2. Siegel, Peter M: 6 articles (01/2022 - 04/2010)
3. Keler, Tibor: 5 articles (01/2022 - 11/2014)
4. Rose, April A N: 5 articles (01/2022 - 04/2010)
5. Crowley, Elizabeth: 5 articles (08/2020 - 11/2014)
6. Simantov, Ronit: 4 articles (11/2014 - 04/2010)
7. Annis, Matthew G: 3 articles (01/2022 - 01/2013)
8. Biondini, Marco: 3 articles (01/2022 - 12/2016)
9. Turner, Christopher D: 3 articles (05/2021 - 01/2019)
10. Vahdat, Linda T: 3 articles (05/2021 - 02/2012)

Related Diseases

1. Melanoma (Melanoma, Malignant)
2. Breast Neoplasms (Breast Cancer)
3. Neoplasms (Cancer)
4. Uveal melanoma
5. Triple Negative Breast Neoplasms

Related Drugs and Biologics

1. Immunoconjugates (Immunoconjugate)
2. Glycoproteins (Glycoprotein)
3. Mitogen-Activated Protein Kinase Kinases (MEKs)
4. 8- (6- methoxypyridin- 3- yl)- 3- methyl- 1- (4- piperazin- 1- yl- 3- trifluoromethylphenyl)- 1,3- dihydroimidazo(4,5- c)quinolin- 2- one
5. mithramycin A
6. Dasatinib (BMS 354825)
7. glembatumumab vedotin
8. monomethyl auristatin E
9. Monoclonal Antibodies
10. tanezumab

Related Therapies and Procedures

1. Subcutaneous Injections
2. Aftercare (After-Treatment)
3. Therapeutics
4. Drug Therapy (Chemotherapy)